Top Institutions in Ophthalmology - Retinal Diseases
Institutions leading in this area are recognized for their pioneering clinical trials, translational research on retinal vascular diseases, and development of innovative drug delivery systems for retinal therapeutics, particularly in anti-VEGF and TKI agents.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research and clinical trials, particularly in novel therapies for AMD and diabetic retinopathy, with extensive expertise in anti-VEGF and emerging TKI treatments.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers worldwide, with a strong focus on diabetic retinopathy and AMD, leading innovative research in anti-VEGF therapies and early adoption of TKI clinical studies.
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a long-standing reputation for excellence in retinal disease management and research, actively participating in clinical trials of new therapeutics including TKIs for neovascular AMD and diabetic retinopathy.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its molecular and clinical research in retinal diseases, contributing significantly to understanding VEGF pathways and developing targeted therapies including TKIs.
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong clinical and research program in retinal diseases, with ongoing studies on innovative treatments including TKIs and sustained delivery systems for AMD and diabetic retinopathy.
